Undefined phenotype
A CLAD phenotype used for presentations that meet the CLAD criteria but do not fit BOS, RAS or mixed.
As of . Primary source: Magnusson et al. 2026 (open access).
Summary
The 2026 ScanCLAD study describes the undefined category as presentations meeting CLAD criteria but not fitting the BOS, RAS or mixed definitions, and it adds a separate unclassifiable category for presentations that the current consensus criteria do not cover. An open-access review of the 2019 scheme lists two types of undefined phenotype in its table.
Sources and links
Related
Links from this record
- described in: Phenotyping of chronic lung allograft dysfunction in the ScanCLAD study
- defined in: Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment: A consensus report from the Pulmonary Council of the ISHLT
- summarised in: Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
Linked from (derived)
- classifies: Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system
- compares: Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system
- discusses: Phenotyping of chronic lung allograft dysfunction in the ScanCLAD study
- defines: Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment: A consensus report from the Pulmonary Council of the ISHLT
- describes: Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
- affects: Clinical CLAD phenotypes are hard to assign reproducibly
Known gaps in this record
- the two undefined sub-types are not described here (table detail not captured)
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.